Answers are grounded in this paper and cite their sources.
A highly cited systematic review of meta-analyses and randomized trials of screening [1] and accompanying commentaries [2, 3] published in the International Journal of Epidemiology in 2015 questioned the benefit of mammography screening, building on the Cochrane review findings on the benefits and harms [4]. Ten years later, a new publication has provided epidemiological evidence relevant to the screening policy debate in the form of observed increases in ductal carcinoma in situ (DCIS) incidence in northern Italy [4, 5]. In a comprehensive age–period–cohort analysis, Bucchi et al. evaluated changes in the DCIS incidence rates over 1992–2017, including the period of mammography-screening introduction and its progressive expansion to different age groups. Their findings suggest that the availability of screening likely accounted for most of the increases in DCIS diagnosis, with possible explanations for the remainder including increased use of diagnostic mammography and increased prevalence of breast cancer risk factors (such as fewer births and older age at first pregnancy). Alongside observations of no decrease in invasive breast cancer incidence (which the treatment of DCIS aims to prevent) in northern Italy after screening was established (2013–2017) [6], these findings suggest that there may have been no benefit for many of the Italian women diagnosed and treated for DCIS. Simply put, detecting and treating DCIS may not prevent a subsequent diagnosis of invasive cancer.
No takes yet. Share an insight, caveat, or question.
Bell et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: